Add this result to my export selection Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 11 December 2019 These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for... Read Summary Type: Guidance (Remove filter)
Add this result to my export selection BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 28 May 2012 These guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based... Read Summary Type: Guidance (Remove filter)
Add this result to my export selection EUnetHTA Joint Action 3 WP4: Repetitive transcranial magnetic stimulation for treatment-resistant major depression (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 24 April 2017 The purpose of the assessment is to examine the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in adult patients with treatment-resistant major depression. The... Read Summary Type: Health Technology Assessments (Remove filter)